0 Comments
0 Shares
235 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Antisense Oligonucleotide for Cardiometabolic Disorders Market Advances with Precision Therapeutics and RNA-Based Drug DevelopmentAccording to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Cardiometabolic Disorders Market The global antisense oligonucleotide for cardiometabolic disorders market size was valued at USD 310.32 million in 2024 and is expected to reach USD 1,135.19 million by 2032, at a CAGR of 17.60% during the forecast...0 Comments 0 Shares 147 Views 0 Reviews
-
Bio simulation Market to Surge to USD 16.69 Billion by 2032 Riding a 16.23% CAGR on Rising Biologics R&D, AI-Enabled Modelling and Demand for Cost-Efficient Drug DevelopmentBiosimulation Market remarkable growth is being driven by a confluence of factors: rapid expansion in biologics and biosimilar development, the escalating burden of chronic diseases, rising demand for precision medicine, and regulatory momentum favoring in-silico simulation to streamline drug development, reduce costs, and accelerate time-to-market. Quick Insights...0 Comments 0 Shares 5K Views 0 Reviews
-
Bio simulation Market to Surge to USD 16.69 Billion by 2032 Riding a 16.23% CAGR on Rising Biologics R&D, AI-Enabled Modelling and Demand for Cost-Efficient Drug DevelopmentBiosimulation Market remarkable growth is being driven by a confluence of factors: rapid expansion in biologics and biosimilar development, the escalating burden of chronic diseases, rising demand for precision medicine, and regulatory momentum favoring in-silico simulation to streamline drug development, reduce costs, and accelerate time-to-market. Quick Insights...0 Comments 0 Shares 5K Views 0 Reviews
-
Bioanalytical Testing Services Industry Witnesses Strong Demand Amid Increasing Drug Development ProgramsThe global bioanalytical testing services market was valued at USD 2.11 billion in 2021. The market is anticipated to expand at a CAGR of 15.7% from 2022 to 2031 and is expected to reach more than USD 8.95 billion by 2031. Rising investments in drug discovery and development, increasing outsourcing of laboratory services, and growing demand for biologics and biosimilars are driving market...0 Comments 0 Shares 321 Views 0 Reviews
-
Broad-Spectrum Antiviral Therapeutics Market Advances with Rising Preparedness for Emerging Viral Outbreaks and Next-Generation Antiviral Drug DevelopmentAccording to the latest report published by Data Bridge Market Research, the Broad-Spectrum Antiviral Therapeutics Market The global broad-spectrum antiviral therapeutics market size was valued at USD 5.84 billion in 2025 and is expected to reach USD 16.08 billion by 2033, at a CAGR of 13.50% during the forecast period Salient attributes used while forming an influential...0 Comments 0 Shares 492 Views 0 Reviews
-
Cell Culture Media Market Benefits from Expanding Vaccine Development and Drug DiscoveryThe global cell culture media market size was valued at USD 6.12 Billion in 2026 and is forecast to expand at a CAGR of 13.4 % from 2026 to 2034, signalling robust demand across differentiated end-uses and media types. This segmentation-driven growth reflects product-differentiation imperatives, application-specific growth trajectories and value-chain optimisation by suppliers pursuing...0 Comments 0 Shares 386 Views 0 Reviews
-
Contract Manufacturing and Targeted Drug Development Fuel HPAPI Market Growth WorldwideModern medicine increasingly relies on powerful therapies that work at extremely small doses. Many breakthrough drugs for cancer, hormonal disorders, and targeted therapies depend on compounds that are highly potent yet precisely controlled. These substances are known as High Potency Active Pharmaceutical Ingredients (HPAPIs). The HP (High Potency) Active Pharmaceutical...0 Comments 0 Shares 2K Views 0 Reviews
-
DiGeorge Syndrome Drug Market Advances with Progress in Rare Disease Research and Development of Targeted Therapeutic ApproachesAccording to the latest report published by Data Bridge Market Research, the DiGeorge Syndrome Drug Market The global DiGeorge Syndrome Drug Market was valued at USD 365.4 million in 2024 and is expected to reach USD 608.7 million by 2032.During the forecast period of 2025 to 2032, the market is projected to grow at a CAGR of 6.5% DiGeorge Syndrome Drug Market is the finest...0 Comments 0 Shares 416 Views 0 Reviews
-
Drug of Abuse Testing Market Growth, Comprehensive Analysis Reveals Superb Development Analysis By FMIThe global diagnostics and public safety landscape is undergoing a critical transformation as drug screening shifts from discretionary testing to a compliance-critical diagnostic service. Driven by rising substance use, regulatory enforcement, and expanding institutional screening programs, the Drug of Abuse Testing Market valued at USD 5.41 billion in 2026 is projected to reach USD 8.98...0 Comments 0 Shares 736 Views 0 Reviews
-
Ear Infection Treatment Market Benefits from Continuous Drug DevelopmentTechnological advancements in diagnostic equipment are positively influencing the Ear Infection Treatment Market. Modern otoscopic imaging systems and improved diagnostic procedures allow healthcare professionals to identify infections earlier, enabling prompt treatment and reducing the likelihood of long-term hearing complications. According to The Insight Partners, the Ear Infection...0 Comments 0 Shares 198 Views 0 Reviews
-
Ensuring Safety and Compliance: The Role of Pharmaceutical Heavy Metal Testing in Drug DevelopmentIn the pharmaceutical industry, the presence of heavy metals—more accurately referred to as elemental impurities—poses significant risks to both product integrity and regulatory compliance. As global health authorities increasingly tighten control over such contaminants, Pharmaceutical Heavy Metal Testing has emerged as a critical requirement in every stage of drug development...0 Comments 0 Shares 927 Views 0 Reviews
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 9K Views 0 Reviews
-
"Peptide and Oligonucleotide CDMO Market Forecast: What to Expect as it Expands by 12.5% CAGR"In addition to regulatory challenges, CDMOs are also addressing the sustainability concerns of the biopharmaceutical industry. Companies are seeking manufacturing solutions that reduce waste, improve energy efficiency, and use sustainable raw materials. As the industry continues to evolve, the ability of CDMOs to offer eco-friendly and sustainable manufacturing practices will be crucial in...0 Comments 0 Shares 7K Views 0 Reviews1
-
Anti-Radiation Drug Advancements Supporting Global Emergency ResponseThe market is benefiting from rising healthcare infrastructure investments across emerging economies. Improved access to advanced treatments is driving adoption. Growing medical preparedness frameworks support sustained expansion. The Anti-Radiation Drugs Market is expanding steadily as healthcare systems strengthen preparedness for radiation exposure risks across medical, industrial, and...0 Comments 0 Shares 9K Views 0 Reviews
-
Autoimmune Polyglandular Syndrome Type 1 Market Revenue ForecastAutoimmune Polyglandular Syndrome Type 1 (APS-1) is a rare inherited autoimmune disorder characterized by the dysfunction of multiple endocrine glands, resulting in chronic health complications that require lifelong medical management. Growing awareness of rare autoimmune diseases, advancements in diagnostic technologies, and increasing investments in targeted therapies are contributing to the...0 Comments 0 Shares 896 Views 0 Reviews
-
Castleman Disease Drug Market Growth, Pipeline Analysis & Global Forecast"Castleman Disease Drug Market According to the latest report published by Data Bridge Market Research, the Castleman Disease Drug Market The global Castleman Disease drug market was valued at USD 231.78 million in 2024 and is expected to reach USD 342.44 million by 2032 and is projected to grow at a CAGR of 5.0%, primarily driven by the...0 Comments 0 Shares 322 Views 0 Reviews
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Comments 0 Shares 2K Views 0 Reviews
-
Contract Manufacturing Boom Supporting API CDMO Market ExpansionRegulatory complexity in drug manufacturing is encouraging companies to rely on specialized CDMOs.Expert compliance management reduces operational risks and delays.This support is critical for global market expansion. Active Pharmaceutical Ingredients CDMO market The market is expected to grow steadily at a CAGR of 7.4% from 2025 to 2031, driven by innovation in drug development and the global...0 Comments 0 Shares 9K Views 0 Reviews2
-
CRPS Market Growth Opportunities in the Global Pain Management SectorContinuous advancements in medical research are playing an important role in shaping the CRPS treatment market. Scientists are exploring innovative therapies aimed at reducing inflammation and nerve damage associated with the disorder. These research initiatives are expected to drive future market developments. The Complex Regional Pain Syndrome (CRPS) Market is projected to grow steadily...0 Comments 0 Shares 6K Views 0 Reviews2
-
Geriatric Medicines Market Demand Analysis and Future ProspectsRising healthcare expenditure for elderly care is contributing to consistent market growth. Governments and private institutions are investing in aging population management programs. This financial support enhances the adoption of specialized medicines. The geriatric medicines market is witnessing strong and sustained growth as healthcare systems worldwide adapt to the needs of an aging...0 Comments 0 Shares 7K Views 0 Reviews
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Comments 0 Shares 3K Views 0 Reviews
-
Global Healthcare CMO Market Forecast 2031: Key DriversThe global healthcare contract manufacturing organization (CMO) market is witnessing rapid expansion due to increasing outsourcing trends, rising demand for complex therapeutics, and advancements in manufacturing technologies. CMOs play a vital role in supporting pharmaceutical, biotechnology, and medical device companies by offering specialized manufacturing, development, and packaging...0 Comments 0 Shares 1K Views 0 Reviews
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Comments 0 Shares 4K Views 0 Reviews
More Results